Fact CheckerSign in

NCT07278583Recruiting

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Evaluation of Eligibility Criteria for Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort

Source: ClinicalTrials.gov · Last updated 30 Jul 2026

Brief summary (registry, in English)

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Status (registry)
Recruiting
Study type
Observational
Enrollment
130 (estimated)
First submitted
1 Dec 2025
Start date
5 Dec 2025
Primary completion date
31 Dec 2026
Lead sponsor
University Hospital, Clermont-Ferrand
NCT number
NCT07278583

What you commit to

  • Study type: Observational
  • Planned participants: 130
  • From 5 Dec 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Who the study is looking for

  • adults
  • able to read and understand french
  • included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Clermont-Ferrand
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.